galantamine has been researched along with Aging in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Amendolagine, FI; Arcidiacono, D; Baraldo, M; Beliën, AT; Blaauw, B; Ciciliot, S; Detienne, G; Ferrarese, G; Masiero, G; Mercken, EM; Nogara, L; Realdon, S; Sandri, M; Tezze, C; Zaramella, A | 1 |
| Klaassen, ES; Klaassens, BL; Rombouts, SARB; van der Grond, J; van Gerven, JMA | 1 |
| Eap, CB; Noetzli, M | 1 |
| Chukhlovina, ML | 1 |
| Benetti, F; Bonini, JS; Cammarota, M; Izquierdo, I; Mello, PB; Monteiro, S | 1 |
| Lehr, MA; Li, JG; Liu-Chen, LY; Woodruff-Pak, DS | 1 |
| Bentué-Ferrer, D; Bordet, R; Förstl, H; Nieoullon, A; Tsolaki, M | 1 |
| Aw, CC; Browne, ER; Chen, CP; Goh, CW; Lee, JH | 1 |
| Stefanacci, RG | 1 |
| Kanno, T; Nishizaki, T; Shimizu, T; Tanaka, A; Yaguchi, T | 1 |
| Bezard, E; Jianzhong, Y; Li, Q; Pioli, EY; Schneider, JS | 1 |
| Guillou, C; Lamirault, L; Simon, H; Thal, C | 1 |
| Ihl, R | 1 |
| Feiro, OR; Gould, TJ | 1 |
| Davis, LW; Gearhart, DA; Hernandez, CM; Hohnadel, EJ; Middlemore, ML; Parikh, V; Terry, AV; Waller, JL; Warsi, SP | 1 |
| Disterhoft, JF; Oh, MM; Power, JM; Wu, WW | 1 |
| Bimonte-Nelson, HA; French, KL; Granholm, AC | 1 |
| Vogel, RW; Wenk, GL; Woodruff-Pak, DS | 1 |
| Bickel, U; Fischer, JP; Kewitz, H; Thomsen, T | 1 |
4 review(s) available for galantamine and Aging
| Article | Year |
|---|---|
Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Pharmacogenetics; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine | 2013 |
[Pathogenetic mechanisms of dementia in the older patients with Parkinson's diseases].
Topics: Aging; alpha-Synuclein; Aminoquinolines; Cholinergic Neurons; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Male; Mutation; Parkinson Disease; Phenylcarbamates; Protein Kinases; Rivastigmine | 2014 |
Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine*.
Topics: Acetylcholine; Activity Cycles; Aging; Alzheimer Disease; Cholinesterase Inhibitors; Female; Galantamine; Humans; Male; Memory; Sleep Stages | 2008 |
The costs of Alzheimer's disease and the value of effective therapies.
Topics: Age Factors; Aging; Alzheimer Disease; Cholinesterase Inhibitors; Disease Progression; Donepezil; Galantamine; Health Care Costs; Health Expenditures; Humans; Indans; Medicare; Medicare Part D; Memantine; Piperidines; Psychometrics; United States | 2011 |
1 trial(s) available for galantamine and Aging
| Article | Year |
|---|---|
Serotonergic and cholinergic modulation of functional brain connectivity: A comparison between young and older adults.
Topics: Adolescent; Adult; Aged; Aging; Cerebral Cortex; Cholinesterase Inhibitors; Citalopram; Connectome; Cross-Over Studies; Double-Blind Method; Female; Galantamine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Selective Serotonin Reuptake Inhibitors; Young Adult | 2018 |
14 other study(ies) available for galantamine and Aging
| Article | Year |
|---|---|
A combination of metformin and galantamine exhibits synergistic benefits in the treatment of sarcopenia.
Topics: Aged; Aging; Animals; Galantamine; Humans; Infant; Metformin; Mice; Mice, Transgenic; Muscle, Skeletal; Sarcopenia | 2023 |
Early postnatal maternal deprivation in rats induces memory deficits in adult life that can be reversed by donepezil and galantamine.
Topics: Acetylcholine; Acetylcholinesterase; Aging; Animals; Animals, Newborn; Brain; Disease Models, Animal; Donepezil; Female; Galantamine; Hippocampus; Indans; Learning Disabilities; Male; Maternal Deprivation; Memory Disorders; Neuropsychological Tests; Nootropic Agents; Piperidines; Rats; Rats, Wistar; Social Behavior | 2009 |
Young and older good learners have higher levels of brain nicotinic receptor binding.
Topics: Acetylcholine; Aconitine; Aging; Analysis of Variance; Animals; Behavior, Animal; Binding, Competitive; Blinking; Brain; Bridged-Ring Compounds; Cholinesterase Inhibitors; Conditioning, Classical; Dose-Response Relationship, Drug; Epinephrine; Female; Galantamine; Learning; Nicotinic Antagonists; Protein Binding; Rabbits; Radioligand Assay; Receptors, Nicotinic; Spiro Compounds; Tritium | 2010 |
Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats.
Topics: Aging; Animals; Biological Availability; Brain; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Dose-Response Relationship, Drug; Galantamine; Half-Life; Hypothermia; Indans; Male; Metabolic Clearance Rate; Piperidines; Random Allocation; Rats; Rats, Inbred Strains; Receptor, Muscarinic M2; Salivation; Tacrine; Tears; Tremor | 2011 |
8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid and its diastereomers improve age-related cognitive deterioration.
Topics: Aging; Animals; Caprylates; Cholinesterase Inhibitors; Cognition Disorders; Galantamine; Male; Memory Disorders; Mice | 2012 |
Effects of memantine and galantamine on cognitive performance in aged rhesus macaques.
Topics: Aging; Animals; Association Learning; Cognition; Galantamine; Macaca mulatta; Male; Memantine; Treatment Outcome | 2013 |
(-)-9-Dehydrogalanthaminium bromide, a new cholinesterase inhibitor, enhances place and object recognition memory in young and old rats.
Topics: Age Factors; Aging; Animals; Cholinesterase Inhibitors; Cognition; Galantamine; Injections; Male; Maze Learning; Memory; Rats; Rats, Sprague-Dawley; Recognition, Psychology | 2003 |
The impact of drugs against dementia on cognition in aging and mild cognitive impairment.
Topics: Adult; Aged; Aged, 80 and over; Aging; Cognition; Cognition Disorders; Dementia; Donepezil; Female; Galantamine; Ginkgo biloba; Humans; Indans; Male; MEDLINE; Middle Aged; Nootropic Agents; Piperidines; Plant Extracts | 2003 |
Age-related deficits in the retention of memories for cued fear conditioning are reversed by galantamine treatment.
Topics: Acoustic Stimulation; Aging; Amygdala; Analysis of Variance; Animals; Association Learning; Cholinergic Fibers; Cholinesterase Inhibitors; Conditioning, Classical; Fear; Freezing Reaction, Cataleptic; Galantamine; Hippocampus; Male; Mice; Mice, Inbred C57BL; Nicotinic Agonists; Nootropic Agents; Retention, Psychology | 2005 |
Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.
Topics: Acetylcholinesterase; Aging; Animals; Autoradiography; Brain; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Donepezil; Enzyme-Linked Immunosorbent Assay; Galantamine; Indans; Injections, Subcutaneous; Male; Maze Learning; Memory; Motor Activity; Nerve Growth Factor; Piperidines; Rats; Rats, Inbred F344; Receptors, Cholinergic; Vesicular Acetylcholine Transport Proteins | 2006 |
Galantamine increases excitability of CA1 hippocampal pyramidal neurons.
Topics: Action Potentials; Aging; Animals; Atropine; Bungarotoxins; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Female; Galantamine; Hippocampus; Muscarinic Antagonists; Nicotinic Antagonists; Organ Culture Techniques; Patch-Clamp Techniques; Pyramidal Cells; Rabbits; Receptors, Muscarinic; Receptors, Nicotinic; Synaptic Transmission | 2006 |
Galantamine effects on memory, spatial cue utilization, and neurotrophic factors in aged female rats.
Topics: Aging; Animals; Behavior, Animal; Body Weight; Cholinesterase Inhibitors; Cues; Female; Galantamine; Humans; Male; Maze Learning; Memory; Nerve Growth Factors; Perception; Rats; Rats, Inbred F344; Spatial Behavior | 2007 |
Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning.
Topics: Acetylcholinesterase; Aging; Animals; Behavior, Animal; Cholinesterase Inhibitors; Female; Galantamine; Learning; Protein Binding; Rabbits; Receptors, Nicotinic | 2001 |
Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans.
Topics: Administration, Oral; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Galantamine; Humans; Male; Stereoisomerism; Structure-Activity Relationship | 1990 |